TR
Tessa Romero JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
18%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
69.6%
Neutral
21.7%
Negative
8.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $25 |
12%
downside
| 2 | – |
–
| 6 Jan ‘26 2 days ago |
|
|
|
Overweight
Initiated
| $38 |
74%
upside
| 1 | +12% |
0
%
| 19 Dec ‘25 20 days ago |
|
|
|
Overweight
Maintained
| $15 |
31%
upside
| 3 | -23% |
0
%
| 20 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $60 |
45%
upside
| 1 | +1.9% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $47 |
12%
upside
| 1 | +16% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Underweight
Downgraded
| $263 |
6,803%
upside
| 1 | -24% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $31 |
15%
upside
| 5 | +9.2% |
0
%
| 17 Nov ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $17 |
7%
downside
| 3 | – |
–
| 14 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $34 |
39%
upside
| 3 | +21% |
0
%
| 14 Nov ‘25 1 month ago |
|
|
|
Underweight
Downgraded
| – | – | 1 | -47% |
0
%
| 16 Sep ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $53 |
16%
downside
| 1 | +98% |
0
%
| 9 Jun ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $10 |
6%
upside
| 1 | +230% |
0
%
| 30 May ‘25 7 months ago |
|